[1]修朋程,李 腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(09):8-11.[doi:10.3969/j.issn.1006-1959.2018.09.003]
　XIU Peng-cheng,LI Teng,LI Ya-lin,et al.Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice[J].Journal of Medical Information,2018,31(09):8-11.[doi:10.3969/j.issn.1006-1959.2018.09.003]
点击复制

泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年09期
页码:
8-11
栏目:
出版日期:
2018-05-01

文章信息/Info

Title:
Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice
文章编号:
1006-1959（2018）09-0008-04
作者:
修朋程; 李 腾; 李雅林; 刘纪豪; 李 栋; 刘有旺
泰山医学院，山东 泰安 271000
Author(s):
XIU Peng-cheng; LI Teng; LI Ya-lin; LIU Ji-hao; LI Dong; LIU You-wang
Taishan Medical College,Tai'an 271000,Shandong,China
关键词:
泰山山慈菇; 肝癌; 肿瘤坏死因子-α; 白细胞介素-2; γ-干扰素
Keywords:
Key words：Taishan mountain mushroom; Liver cancer; Tumor necrosis factor -α; Interleukin-2; γ-interferon
分类号:
R392.3
DOI:
10.3969/j.issn.1006-1959.2018.09.003
文献标志码:
A
摘要:
目的 探讨泰山山慈菇对小鼠肝癌的免疫治疗作用。方法 本课题首先制备泰山山慈菇提取液，体外用山慈菇提取液对H22肝癌细胞进行干预，分为空白组、山慈菇提取液低、中、高剂量组和5-氟尿嘧啶阳性对照组，干预12 h后，Annexin V和7-AAD染色，流式细胞术检测细胞凋亡。体内制备小鼠H22实体瘤肝癌模型，将50只小鼠分为山慈菇低、中、高剂量组、5-Fu阳性对照组、模型对照组，每组10只。山慈菇各剂量组均进行灌胃治疗，模型组灌胃等体积生理盐水，5-Fu阳性对照组进行等体积腹腔注射。连续 10 d，停药后次日摘取小鼠眼球取血后颈椎脱臼处死小鼠，检测小鼠肿瘤大小分析对肿瘤的抑制作用。酶联免疫吸附试验（ELISA）检测血清中肿瘤坏死因子-α（TNF-α）、白细胞介素-2（IL-2）和γ-干扰素（IFN-γ）的含量。结果 泰山山慈菇提取液体外促进H22肿瘤细胞凋亡且具有剂量依赖性。体内抑制H22肿瘤的生长，增加血清中TNF-α、IL-2和IFN-γ的含量且呈现剂量依赖性。结论 泰山山慈菇通过增加抗肿瘤细胞因子产生发挥抗肿瘤作用。
Abstract:
Abstract：Objective To investigate the immunotherapy effect of Taishan mountain mushroom on liver cancer in mice.Methods We first prepared the Taishan mountain mushroom extract.In vitro,the H22 hepatoma cells were treated with the extract of mushroom extract in vitro.It was divided into blank group,low,middle and high dose group and 5- fluorouracil positive control group.After 12 h intervention,Annexin V and 7-AAD were stained,and cell apoptosis was detected by flow cytometry.The mice model of H22 solid tumor was prepared in vivo,and 50 mice were divided into low,medium and high dose group,5-Fu positive control group and model control group,with 10 rats in each group.The rats in each dose group were treated by intragastric perfusion,and the model group was given iso-volume intraperitoneal injection of normal saline and 5-Fu positive control group.For 10 d,the mice were killed the next day after extirpation of eyeball and blood,and the inhibitory effect of tumor size analysis on the tumor was detected.Enzyme-linked immunosorbent assay(ELISA)was used to detect the levels of TNF-α,IL-2 and IFN-γ in serum.Results The extract of Taishan mountain mushroom promoted the apoptosis of H22 tumor cells in a dose-dependent manner.In vivo,the growth of H22 tumor was inhibited and the levels of TNF-α,IL-2 and IFN-γ in serum increased.Conclusion Taishan mountain mushroom plays an anti-tumor role by increasing the production of anti-tumor cytokines.

参考文献/References:

[1]林增榕.阿司匹林对小鼠腹水型肝癌H22的作用研究[J].海峡药学,2015,27(11):20-22.
[2]吴俊林,卢德成,罗佐杰,等.中药山慈姑对甲状腺癌细胞的促凋亡作用[J].时珍国医国药,2014,25(1):71-74.
[3]林如辉,李钻芳,曾建伟,等.山慈姑醇提取液对SGC-7901细胞的抗肿瘤机制[J].福建中医药大学学报,2012,22(5):22-24.
[4]徐小娟,蔡懿鑫,毛宇,等.山慈菇多糖对荷H22肝癌小鼠的抗肿瘤机制研究[J].食品研究与开发,2015,36(7):23-25.
[5]Higgs JT,Lee JH,Wang H,et al.Mesenchymal stem cells expressing osteoprotegerin variants inhibit osteolysis in a murine model of multiple myeloma[J].Blood Adv,2017,1(25):2375-2385.
[6]黄展,辛华,江旭东,等.独角莲醇提液对H22肝癌荷瘤小鼠血清IL-2和TNF-α水平的影响[J].肿瘤药学,2013,3(6):432-435.
[7]Naimi A,Movassaghpour AA,Hagh MF,et al.Tnf-related apoptosis-inducing ligand(trail)as the potential therapeutic target in hematological malignancies[J].Biomed Pharmacother,2017(98):566-576.
[8]薛瑞,曹军华,李瑞生,等.参芪扶正注射液对肝癌细胞株H22的抑制作用及机制研究[J].实用药物与临床,2014,17(5):544-546.

相似文献/References:

[1]崔康健,杜成友.肝动脉化疗栓塞联合射频消融治疗肝癌的研究进展[J].医学信息,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
　CUI Kang-jian,DU Cheng-you.Research Progress of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Cancer[J].Journal of Medical Information,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
[2]田 明,常伟平.UbcH10在肝癌中的表达及其与预后的关系[J].医学信息,2019,32(12):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
　IAN Ming,CHANG Wei-ping.Expression of UbcH10 in Hepatocellular Carcinoma and Its Relationship with Prognosis[J].Journal of Medical Information,2019,32(09):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
[3]许 吉.基于知识图谱和专利地图的我国抗肝癌药物研发态势研究[J].医学信息,2018,31(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
　XU Ji.Research and Development Situation of Anti-liver Cancer Drugs in China Based on Knowledge Map and Patent Map[J].Journal of Medical Information,2018,31(09):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
[4]兰福全,李秀云,卢 斌.四种肿瘤标志物对肝癌诊断的临床意义[J].医学信息,2018,31(21):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
　LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Journal of Medical Information,2018,31(09):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
[5]李 闯,叶劲松,刘 昕,等.ZBP-89与缺氧信号因子HIF-1α在肝癌细胞中的 相关性研究[J].医学信息,2019,32(15):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
　LI Chuang,YE Jin-song,LIU Xin,et al.Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells[J].Journal of Medical Information,2019,32(09):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
[6]赵瑶瑶,高 川,胡佳杰.循环miRNA监测肝细癌的研究[J].医学信息,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
　ZHAO Yao-yao,GAO Chuan,HU Jia-jie.Research on the Study of Circulating miRNA for Monitoring Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(09):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
[7]孙 逊.性化护理对肝癌患者CT引导下射频消融术后 负性情绪及生活质量的影响[J].医学信息,2019,32(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
　SUN Xun.Effect of Humanized Nursing on Negative Emotion and Quality of Life after CT-guided Radiofrequency Ablation in Patients with Liver Cancer[J].Journal of Medical Information,2019,32(09):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
[8]徐 蓓,魏霞丽,常艳琴.肝癌患者术后自我饮食管理体验的质性研究[J].医学信息,2019,32(20):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
　XU Bei,WEI Xia-li,CHANG Yan-qin.Qualitative Study of Postoperative Self-Catering Management Experience in Patients with Liver Cancer[J].Journal of Medical Information,2019,32(09):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
[9]刘申颖,施彦卿,梅鹏飞,等.超声引导下经皮无水乙醇注射联合射频消融治疗中晚期肝癌的效果[J].医学信息,2019,32(22):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]
　LIU Shen-ying,SHI Yan-qing,MEI Peng-fei,et al.Ultrasound-guided Percutaneous Ethanol Injection Combined with Radiofrequency Ablation for Advanced Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(09):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]
[10]任勇军,闵旭立,徐 浩,等.洛铂联合表柔比星化疗栓塞治疗原发性肝细胞癌的疗效[J].医学信息,2019,32(24):43.[doi:10.3969/j.issn.1006-1959.2019.24.014]
　REN Yong-jun,MIN Xu-li,XU Hao,et al.Efficacy of Loplatin Combined with Epirubicin Chemotherapy and Embolization for Primary Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(09):43.[doi:10.3969/j.issn.1006-1959.2019.24.014]

更新日期/Last Update: 2018-05-01